Project Number 3R01AG048678-04S1 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for DEVELOPMENT OF NOVEL THERAPEUTIC ANTI-TAU ANTIBODIES Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator DIAMOND, MARC I Principal Investigator First Name MARC Principal Investigator Last Name DIAMOND Awardee Organization UT SOUTHWESTERN MEDICAL CENTER Awardee State Texas Contact PI Country United States Project Detail Funding Opportunity Announcement PA-16-288: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) FY Overall Cost $73,721 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO Related Resources Repository [AlzPED] AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy.
